
### [NCIT:C7580](http://purl.obolibrary.org/obo/NCIT_C7580)
**Label:** Skin Appendage Adenoma

**Subclasses:** [NCIT:C40312](http://purl.obolibrary.org/obo/NCIT_C40312) (Vulvar Nodular Hidradenoma), [NCIT:C4168](http://purl.obolibrary.org/obo/NCIT_C4168) (Apocrine Adenoma), [NCIT:C7568](http://purl.obolibrary.org/obo/NCIT_C7568) (Nodular Hidradenoma), [NCIT:C7567](http://purl.obolibrary.org/obo/NCIT_C7567) (Clear Cell Hidradenoma), [NCIT:C27527](http://purl.obolibrary.org/obo/NCIT_C27527) (Tubular Apocrine Adenoma), [NCIT:C7563](http://purl.obolibrary.org/obo/NCIT_C7563) (Hidradenoma), [NCIT:C43342](http://purl.obolibrary.org/obo/NCIT_C43342) (Apocrine Hidrocystoma), [NCIT:C7560](http://purl.obolibrary.org/obo/NCIT_C7560) (Sweat Gland Adenoma), [NCIT:C4174](http://purl.obolibrary.org/obo/NCIT_C4174) (Sebaceous Adenoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 53.12%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 53.12%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.12%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38784](http://purl.obolibrary.org/obo/NCIT_C38784) (Apoptosis Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C3876](http://purl.obolibrary.org/obo/NCIT_C3876) (Gastric Leiomyoma))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38732](http://purl.obolibrary.org/obo/NCIT_C38732) (Defective Alpha Heavy Chain Present))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38731](http://purl.obolibrary.org/obo/NCIT_C38731) (Villous Atrophy))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38730](http://purl.obolibrary.org/obo/NCIT_C38730) (Lymphoepithelial Lesion))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38727](http://purl.obolibrary.org/obo/NCIT_C38727) (Villous Lymphocyte))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism))) 38.48%


